Software As A Medical Device Market 2017: Industry Research, Review, Growth, Segment, Analysis and Forecast to 2022

Software intended to be used for a special medical purpose and is not a part of hardware medical device is called SaMD (Software as a Medical Device)

PUNE, INDIA, April 3, 2017 /EINPresswire.com/ — Global Software As A Medical Device Market Overview

Software intended to be used for a special medical purpose and is not a part of hardware medical device is called SaMD (Software as a Medical Device), for example, software used to assist healthcare professionals with diagnosis. Software adoption for healthcare is increasingly becoming a viable solution that curtails healthcare cost which, in turn, is driving SaMD market. Moreover, factors like growing aging population coupled with government support and healthcare reform further bolster the adoption of SaMD. Owing to increase in number of diseases there is a growing pressure to reduce healthcare cost and to increase the quality of care. In addition, the ongoing research and development and continuous technological advancement in healthcare sector across the globe is expected to augment the SaMD market in years ahead. However, strict government regulation in countries like United States and Europe hampers the market growth. Furthermore, absence of proper standards in developing and underdeveloped countries further restraints the market growth.

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1143315-software-as-a-medical-device-market-samd-market-forecasts-from-2017-to-2022

Research Methodology

Firstly, the report provides a brief introduction of the market and deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segmentations which have been covered as part of the report.

Market Dynamics

Next, the section provides comprehensive market dynamics through an overview section along with growth drivers, challenges, and opportunities which exist in the current market. This section of the report also provides supplier and industry outlook as a whole; key industry, global and regional regulations which are determining the market growth and a brief technological aspect of SaMD Market. Complete industry analysis has also been covered by Porter’s five forces model as a part of this report section.

Segmentation

SaMD Market has been segmented on the basis of device, software type, deployment and geography as follows:

By Device
PCs/Laptop
Smartphone
Tablet
By Software Type
Radiation Therapy Planning Software
Apps for Phones
PACS
Image Processing Software
Standalone Software for Data Collection
Standalone Application Software for Remotely Data Collection
Infusion Pump Rate Setting Assistance Software
Others
By Deployment
Cloud
On-Premise
By Geography
Americas
North America
South America
Europe Middle East and Africa
Europe
Middle East and Africa
Asia Pacific

Market Players

Finally, competitive intelligence section deals with major players in the market, their market shares, growth strategies, products, financials, and recent investments among others. Key industry players profiled as part of this section are Attune, Mckesson Corporation, GE Healthcare, Cerner Corporation, Merge Healthcare, Inc., and Allscripts among others.

Access Complete Report @ https://www.wiseguyreports.com/reports/1143315-software-as-a-medical-device-market-samd-market-forecasts-from-2017-to-2022
Table Of Content

1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1. Market Overview and Segmentation
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Porter's Five Forces
4.6. Supplier Outlook
4.7. Industry Outlook
4.8. Industry Value Chain Analysis
4.9. Scenario Analysis
5. SaMD Market Forecast by Device (US$ billion)
5.1. PCs/Laptop
5.2. Smartphone
5.3. Tablet
6. SaMD Market Forecast by Software Type (US$ billion)
6.1. Radiation Therapy Planning Software
6.2. Smartphone Apps
6.3. PACS
6.4. Image Processing Software
6.5. Standalone Software for Data Collection
6.6. Standalone Application Software for Remotely Data Collection
6.7. Infusion Pump Rate Setting Assistance Software
6.8. Others
7. SaMD Market Forecast by Deployment (US$ billion)
7.1. Cloud
7.2. On Premise
8. SaMD Market Forecast by Geography (US$ billion)
8.1. Americas
8.1.1. North America
8.1.2. South America
8.2. Europe Middle East and Africa
8.2.1. Europe
8.2.2. Middle East and Africa
8.3. Asia Pacific
9. Competitive Intelligence
9.1. Market Share of Key Players
9.2. Investment Analysis
9.3. Recent Deals
9.4. Strategies of Key Players
10. Company Profiles
10.1. Mckesson Corporation
10.2. GE Healthcare
10.3. Cerner Corporation
10.4. Merge Healthcare, Inc.
10.5. Allscripts
10.6. List if not exhaustive*

Purchase Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1143315

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Wilson disease Therapeutic and Drug Pipeline Review H2


.

.

Wilson disease Therapeutics strategies and Product Pipeline Review 2017

PUNE, INDIA, April 3, 2017 /EINPresswire.com/ — Summary
Wilson disease is a rare autosomal recessive inherited disorder of copper metabolism that is characterized by excessive deposition of copper in the liver, brain, and other tissues. Symptoms include abdominal pain, jaundice, problems with speech, swallowing and muscle stiffness. Treatment includes chelators and Vitamin E supplements.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/867092-wilson-disease-pipeline-review-h2-2016

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Wilson Disease – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Wilson Disease (Genetic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Wilson Disease (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Wilson Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I and Preclinical stages are 1, 1 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.
Wilson Disease (Genetic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Wilson Disease (Genetic Disorders).
– The pipeline guide reviews pipeline therapeutics for Wilson Disease (Genetic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Wilson Disease (Genetic Disorders) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Wilson Disease (Genetic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Wilson Disease (Genetic Disorders)

Reasons to buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Wilson Disease (Genetic Disorders).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Wilson Disease (Genetic Disorders) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Content: Key Points
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Wilson Disease Overview 6
Therapeutics Development 7
Pipeline Products for Wilson Disease – Overview 7
Pipeline Products for Wilson Disease – Comparative Analysis 8
Wilson Disease – Therapeutics under Development by Companies 9
Wilson Disease – Therapeutics under Investigation by Universities/Institutes 10
Wilson Disease – Pipeline Products Glance 11
Clinical Stage Products 11
Early Stage Products 12
Wilson Disease – Products under Development by Companies 13
Wilson Disease – Products under Investigation by Universities/Institutes 14
Wilson Disease – Companies Involved in Therapeutics Development 15
Dimension Therapeutics Inc 15
GMP-Orphan SAS 16
Revive Therapeutics Ltd 17
Wilson Therapeutics AB 18
Wilson Disease – Therapeutics Assessment 19
Assessment by Monotherapy Products 19
Assessment by Target 20
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/867092-wilson-disease-pipeline-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Pharmaceutical Filtration Device Market is expected to grow a USD 23 Billion by Forecast to 2022

Pharmaceutical Filtration Market information, by type (Air filtration, water filtration, Grade filtration (liquid and gas) – Forecast to 2022

GE Healthcare (U.S.), Pall Corporation (U.S.), Parker Hannifin Corporation (U.S.), Sartorius Stedim Biotech S.A. (France)”

— Market Research Future

PUNE, MAHARASHTRA, INDIA, April 3, 2017 /EINPresswire.com/ — Market Highlights:
The Global Pharmaceutical Filtration Market has been evaluated as rapidly growing market and it is expected that the market will continue to grow similarly in the near future. Filtration is any of various mechanical, physical or biological operations that distinct solids from fluids (liquids or gases) by adding a medium through which only the fluid can pass. The fluid that passes through is called the filtrate. Filtration is also important and widely used as one of the unit operations of chemical engineering. It may be simultaneously combined with other unit operations to process the feed stream, as in the bio-filter, which is a combined filter and biological digestion device.

Major growth of the market is attributed to increasing incidence of airborne disease, rapid expansion of generics production, and advancements in nano-fiber and other filtrations technology. Also, R&D growth and expenditure Global Pharmaceutical Device Filtration Market on pharmaceutical and biotechnology projects and the rising number of drug development projects are important drivers for the pharmaceutical filtration market. Also the wide application of filtrations such the technique is applied to various applications ranging from the removal of unwanted suspensions to the removal of bacteria from the process material also adds on to the market growth. On the other hand factors such as high regulations on environmental control and government regulation and stringent policies hinder the market growth of the pharmaceutical filtrations market.

Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Pharmaceutical Filtration Market Research Report – Global Forecast to 2022.

Major Key Players:
• GE Healthcare (U.S.)
• Pall Corporation (U.S.)
• Parker Hannifin Corporation (U.S.)
• Sartorius Stedim Biotech S.A. (France)
• Merck KGaA (Germany)
• Alfa Laval (Sweden)
• Graver Technologies, LLC (U.S.)
• Koch Membrane Systems Inc. (U.S.)
• GEA Group (Germany).

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/2432

Study Objectives of Pharmaceutical Filtration Devices Market:
• To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the pharmaceutical filtration market
• To provide insights about factors affecting the market growth
• To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
• To provide country level analysis of the market with respect to the current market size and future prospective
• To provide country level analysis of the market for segments by type, by application, by end user and its sub-segments.
• To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

Regional Analysis:
Depending on geographic region, pharmaceutical filtration market is segmented into four key regions: Americas, Europe, Asia-Pacific, and Middle East & Africa. Considering the global scenario of the market, Americas region is believed to be the largest market for pharmaceutical filtration.

Intended Audience:
• Pharmaceutical filtration device manufacturers and suppliers
• Contract Research Organizations (CROs)
• Research and Development (R&D) Companies
• Government & Independent Research Laboratories
• Government and Independent Regulatory Authorities
• Market Research and Consulting Service Providers
• Academic Institutes and Universities

Segmentation:
Pharmaceutical Filtration market has been segmented on the basis of type which comprises of air filtration, water filtration, chemical filtrations, grade filtration and absorptive filtration. Similarly on the basis of product, the market has been segmented into membrane filters, media filters, cartridges and capsule filtration and others. On the basis of application in pharmaceutical industry the filtrations market has again segment into air purification, water purification, sterilization, cell separation, media and buffer filtrations and others.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/pharmaceutical-filtration-devices-market-2432

The report for Pharmaceutical Filtrations Devices Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market.

Table of Contents
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
Continued…

List of Tables
Table 1 Global Pharmaceutical Filtration Market, By Type, 2013-2022
Table 2 Global Pharmaceutical Filtration Market, By Product, 2013-2022
Table 3 Global Pharmaceutical Filtration Market, 2013-2022
Table 4 Global Pharmaceutical Filtration Market, By Region, 2013-2022

List of Figures
Figure 1 Research Process
Figure 2 Porters Five Forces Model
Figure 3 Global Pharmaceutical Filtration Market, By Type
Figure 4 Global Pharmaceutical Filtration Market, By Product
Figure 5 Global Pharmaceutical Filtration Market, By Application
Figure 6 Global Pharmaceutical Filtration Market, By Region
Figure 7 Global Pharmaceutical Filtration Market:

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Akash Anand
Market Research Future
+1 646 845 9312
email us here


Source: EIN Presswire

Cancer Immunotherapies Treatment Strategies and Product Pipeline Review 2017


.

.

Cancer Immunotherapies Therapeutics Development and Professional Review Analysis 2017

PUNE, INDIA, April 3, 2017 /EINPresswire.com/ — Summary
Cancer is a group of diseases characterized by abnormal cell growth. It is a multi-step process, as a single mutation is almost certainly insufficient to cause a cell to become malignant. A number of cellular processes must be deregulated to allow cells to proliferate uncontrollably while evading apoptosis. Initially, key cell growth, proliferative and pro-apoptotic signaling pathways are deregulated in most cancers. These signaling pathways enable cell survival, continued proliferation, and the avoidance of programmed cell death.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/859277-global-cancer-immunotherapies-market-increasingly-competitive-market

It is now widely believed that many tumors express antigens that can be identified by the adaptive immune system, and that can therefore potentially be used to produce an anti-tumor immune response. The immune system is believed to have the greatest potential in terms of treating cancer, as there is evidence tumors are recognized by the immune system, and this tumor-specific immune response is due to the recognition of tumor antigens. However, in many cancers, disease progression is also accompanied by immune suppression, which hinders an effective anti-tumor response and tumor elimination.
Over the past few decades cancer immunotherapies have developed into important therapeutic options for some types of cancer. Some of these therapies generally enhance the activity of the body’s immune system, while others drive the immune system to target specific cancer cells.
The different types of cancer immunotherapies used to treat cancer include monoclonal antibodies (mAbs) directed at specific tumor-associated antigens (TAA); immune checkpoint inhibitors, which target key proteins involved in the immune response, such as programmed cell death-1 (PD-1); cancer vaccines, which can be used to stimulate an immune response in a patient; and non-specific immunotherapies, which are therapies that do not target cancer cells specifically, but stimulate the immune system in a more general way, such as interferon therapy.
Overall, there are 2,037 products in active development in the cancer immunotherapy pipeline. This makes it a notable portion of the entire oncology pipeline, and reflects the strong interest in this class of therapy in product development. This is due to growing clinical rationale behind developing such therapies, and the willingness of drug developers to invest in novel therapeutics, which will offer significant product differentiation from market competitors.
The leading indications in terms of cancer immunotherapy product development are breast cancer, melanoma, non-small-cell lung cancer (NSCLC) and ovarian cancer, which are the focus of this report. This is based on the high level of activity in terms of cancer immunotherapy product development in these specific oncology indications, with the aforementioned indications ranking highest in this regard.

Scope
The cancer immunotherapies market already consists of some commercially successful products.
– Which classes of drug dominate the market?
– What additional benefits have newly approved therapies brought to the market?
The cancer immunotherapies pipeline is vast, with a significant degree of diversity in terms of molecule types and targets.
– Which molecular targets appear most frequently in the pipeline?
– What are the commercial prospects for the most promising late-stage pipeline products?
The cancer immunotherapies market is forecast to rise from a value of $16.9 billion in 2015 to $75.8 billion in 2022, at a compound annual growth rate of 23.9%.
– Which products are forecast to drive this substantial degree of growth?
– Will generic competition have a significant impact on the market over the forecast period?
The company landscape is growing increasingly competitive.
– What are the leading companies in terms of market share?
– Which companies are forecast to experience the greatest growth in market share?
– What are the drivers of growth for key companies in the market?
– How dependent are the key companies on this disease cluster for revenue?
– Which companies rely heavily on this disease cluster for revenue?

Reasons to buy
This report will allow you to –
– Understand the current clinical and commercial landscape through a comprehensive study of disease epidemiology, pathogenesis, symptoms, diagnosis and prognosis for the key indications covered in the report, which includes breast cancer, melanoma, NSCLC and ovarian cancer.
– Assess the current treatment landscape, with product profiles covering prominent marketed therapies, including revenue forecasts.
– Analyze the cancer immunotherapies pipeline and stratify by stage of development, molecule type, and molecular target. The most promising late-stage therapies are profiled and assessed in terms of clinical performance and competitiveness, alongside a single-product forecast.
– Predict growth in market size, with in-depth market forecasting from 2015 to 2022. The forecasts will provide an understanding of how epidemiology trends, new drug entries, and patent expirations will influence market value.
– Identify the leading companies in the market, in terms of market share and growth. Company analysis determines how dependent the key companies in the market are on revenue derived from cancer immunotherapy products. In addition, analysis determines the primary factors that will drive market growth for the key companies in the market.
– Identify commercial opportunities in the cancer immunotherapies deals landscape by analyzing trends in licensing and co-development deals.

Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 11
2.1 Therapy Area Introduction 11
2.2 Epidemiology 12
2.2.1 Breast Cancer 12
….
8 Appendix 126
8.1 Bibliography 126
8.2 All Pipeline Drugs by Phase of Development 136
8.2.1 Discovery 136
8.2.2 Preclinical 160
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/859277-global-cancer-immunotherapies-market-increasingly-competitive-market

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global HIV Drug / Medicine Market is Anticipated to Grow at a CAGR of 5.93% During 2017 – 2023

HIV Drug market is one of the growing drug markets across the globe. There has been a significant rise in number of HIV population worldwide.

PUNE, INDIA, April 3, 2017 /EINPresswire.com/ — Global HIV Drug Market Overview

HIV Drug market is one of the growing drug markets across the globe. There has been a significant rise in number of HIV population worldwide. On the other hand, increase in number of cases of infection transmission through contaminated needles or infected blood has been registered in last few years. Breast milk, unprotected sex is the most common & big route of HIV to infect a large number of population across the globe and decrease the immunity of protection against infections.

Several government initiatives have been started and awareness programs are entertained in order to minimize the burden of HIV across the globe. Improvements in medicinal therapies like antiretroviral therapy (ART) which are also affordable for the patients suffering from HIV helps in the overall care and also increasing life expectancy of the patients. In 2014, 25 antivirals, 16 vaccines and 3 gene therapies have been introduced in the U.S. to improve treatment facilities with better and effective cure. Several drugs have been recently licensed for the treatment of HIV-1 infected patients. These new drugs include CCR5 co-receptor antagonist which is using for the patients those have developed resistance from previous drugs and therapies.

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1143312-hiv-drug-medicine-market-global-demand-analysis-opportunity-outlook-2023

New developments and introduction of effective and affordable therapies is expected to expand the demand for HIV drugs over the forecast period i.e. 2015-2023.

Market size and forecast

The HIV Drug market is expected to expand at a CAGR of 5.93% during the forecast period 2015-2023. The HIV Drug market is expected to reach USD 38.01 Billion by 2023 from USD 26.9 Billion in 2015.

The U.S. is expected to showcase a lucrative growth in HIV Drug market in the forecast period and HIV Drug market is expected to reach USD 2.2 Billion during the forecast period i.e. 2015-2023 in the region. HIV Drug market is expected to expand at a rapid pace over the forecast period 2015-2023 due to introduction of new and effective drugs with less side-effect which will spur the demand for HIV drugs across the globe.

Market Segmentation

Global HIV Drug Market is further segmented on the basis of drugs type as follows:

Demand Analysis By Original Drugs

Demand Analysis By Generic Drugs

Demand Analysis By Drugs Type

Multi class combination products
Nucleoside reverse transcriptase inhibitors
Non-nucleoside reverse transcriptase inhibitors
Entry inhibitors – CCR5 co-receptor antagonist
Fusion inhibitors
Protease inhibitors
HIV integrase strand transfer inhibitors

By Region

HIV Drug Market is further classified on the basis of region as follows:

North America (United States / U.S., Canada) Market Size and Y-O-Y Growth Analysis
Latin America (Mexico, Brazil, Rest of Latin America) Market Size and Y-O-Y Growth Analysis
Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia Poland, Rest of Eastern Europe) Market Size and Y-O-Y Growth Analysis
Asia-Pacific (China, India, Singapore, Japan, Australia and New Zealand and Rest of Asia) Market Size and Y-O-Y Growth Analysis
Middle East and North Africa (MENA) Market Size and Y-O-Y Growth Analysis

Growth Drivers and challenges

Lack of awareness in under developed nations towards protected sex is likely to further raise the population suffering from HIV which is further believed to increase the growth of HIV drug market across the globe during the forecast period 2015-2023. Advancement in healthcare and drug technology due to huge funding in Research and Development sector would help the companies to develop more effective drugs to restrict the dysfunctions and loss of immunity in the human body and is expected to grow the demand of HIV drug and further enforce the market of HIV drug globally.Further, governmental initiatives and rising awareness towards HIV and its carrier is anticipated to propel the demand for HIV drug market over the forecast period 2015-2023 globally. Apart from this, huge funding from the governmental authorities to provide better facilities and cure at affordable cost will make buyers to adopt the precautions related to HIV which is expected to propel further expand the demand of HIV drug market globally. Availability of Anti-retroviral Therapy (ART) with efficient fixed-dose combination reduces the burden of taking excess of pills to keep the infection inactive on the human body which helps the patients to opt these therapies with minimized number of dose. These therapies are expected to grow the demand of HIV Drug over the forecast period i.e. 2015-2023.

However, lack of availability of better and effective cure for HIV in low income countries would be a challenge for the HIV drug market during the forecast period. It has been notified that major population of HIV infected people is present in Sub-Saharan Africa region where the healthcare facilities are expensive for most of the population due to low disposable income which is expected to hinder the growth of HIV drug market.

Generic drugs present in the market are not affordable for the population of low income nations as manufacturing of drugs through original patents is expected to raise the cost of HIV drugs which would be a huge restraint for the HIV drug market. Addioitnally, experiencing treatment failure in several therapies of fixed dose due to development of resistance or toxicity in the body is a major burden and restraint for the HIV Drug market across the globe.

Key Players

The key developers of HIV Drugs across the globe as follows:

GlaxoSmithKline

Company Overview
Key Product Offerings
Business Strategy
SWOT Analysis
Financials

Johnson and Johnson
Merck
Hetero Drugs
Gilead Sciences

Scope and Context

Overview of the Parent Market

Analyst View

Segmentation

The Global HIV Drug market is segmented as follows:

By Original Drugs Market Size and Y-O-Y Growth Analysis
By Generic Drugs Market Size and Y-O-Y Growth Analysis
By Drugs Type Market Size and Y-O-Y Growth Analysis

By Regions

North America (U.S., Canada) Market Size and Y-O-Y Growth Analysis
……Continued

Purchase Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1143312

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Global Vitamin & Mineral Supplement Market 2017 Sales, Supply, Demand & Analysis Forecast to 2022

Wiseguyreports.Com Publish New Market Research Report On-“Global Vitamin & Mineral Supplement Market 2017 Sales, Supply, Demand & Analysis Forecast to 2022”.

PUNE, INDIA, April 3, 2017 /EINPresswire.com/ —

Vitamin & Mineral Supplement Market 2017

"Water-soluble vitamins. These vitamins pass in and out of the body easily. Most do not build up in the body's cells. Water-soluble vitamins include vitamin C and the B vitamins: thiamine, riboflavin, niacin, pantothenic acid, B6, biotin, folic acid, and B12.
Fat-soluble vitamins. These vitamins are stored in the body's cells and do not pass out of the body as easily as water-soluble vitamins do. Fat-soluble vitamins include vitamins A, D, E, and K. Minerals. These include calcium, copper, iron, magnesium, phosphorus, potassium, selenium, and zinc."

Scope of the Report:
This report focuses on the Vitamin & Mineral Supplement in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1137556-global-vitamin-mineral-supplement-market-by-manufacturers-countries-type-and-application

Market Segment by Manufacturers, this report covers
General Nutrition Centers, Inc.
AMWAY
Puritan’s Pride
Pharmavite
Jamieson
Webber Naturals
Pfizer Inc.
Daiichi Sankyo
Eisai
Salus-Haus
DSM
Hainan Yangshengtang
CSPC Pharmaceutical Group
Sanofi China

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Multivitamin
Single Vitamin
Multi Mineral
Single Mineral

Market Segment by Applications, can be divided into
Men
Women
Children
Others

Complete Report Details @ https://www.wiseguyreports.com/reports/1137556-global-vitamin-mineral-supplement-market-by-manufacturers-countries-type-and-application

Table of Contents

1 Market Overview
1.1 Vitamin & Mineral Supplement Introduction
1.2 Market Analysis by Type
1.2.1 Multivitamin
1.2.2 Single Vitamin
1.2.3 Multi Mineral
1.2.4 Single Mineral
1.3 Market Analysis by Applications
1.3.1 Men
1.3.2 Women
1.3.3 Children
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force

2 Manufacturers Profiles
2.1 General Nutrition Centers, Inc.
2.1.1 Business Overview
2.1.2 Vitamin & Mineral Supplement Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 General Nutrition Centers, Inc. Vitamin & Mineral Supplement Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 AMWAY
2.2.1 Business Overview
2.2.2 Vitamin & Mineral Supplement Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 AMWAY Vitamin & Mineral Supplement Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Puritan’s Pride
2.3.1 Business Overview
2.3.2 Vitamin & Mineral Supplement Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Puritan’s Pride Vitamin & Mineral Supplement Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pharmavite
2.4.1 Business Overview
2.4.2 Vitamin & Mineral Supplement Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
………….

3 Global Vitamin & Mineral Supplement Market Competition, by Manufacturer
3.1 Global Vitamin & Mineral Supplement Sales and Market Share by Manufacturer
3.2 Global Vitamin & Mineral Supplement Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Vitamin & Mineral Supplement Manufacturer Market Share
3.3.2 Top 6 Vitamin & Mineral Supplement Manufacturer Market Share
3.4 Market Competition Trend
……..Continued

Any Query?, Ask Here @ https://www.wiseguyreports.com/enquiry/1137556-global-vitamin-mineral-supplement-market-by-manufacturers-countries-type-and-application

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire